Keywords: biogen, idec, unveils, ph, ii, programs, day

Biogen Idec unveils 20 Ph II programs at 2009 R&D Day; plans to bolster MS franchise

Article | 30 March 2009

Print This

At its 2009 R&D day, US drugmaker Biogen Idec revealed that it has six drugs in registration trials and claimed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in